Investors and Media

Investors and Media

Stay informed about Cambium Bio's latest financial performance, corporate developments, and strategic initiatives. Access our recent financial reports, press releases, and investor presentations, and discover upcoming events to engage with our leadership team. As a publicly-listed company, we are committed to maintaining transparent and timely communication with our shareholders, analysts, and media stakeholders.

Stay informed about Cambium Bio's latest financial performance, corporate developments, and strategic initiatives. Access our recent financial reports, press releases, and investor presentations, and discover upcoming events to engage with our leadership team. As a publicly-listed company, we are committed to maintaining transparent and timely communication with our shareholders, analysts, and media stakeholders.

Stay informed about Cambium Bio's latest financial performance, corporate developments, and strategic initiatives. Access our recent financial reports, press releases, and investor presentations, and discover upcoming events to engage with our leadership team. As a publicly-listed company, we are committed to maintaining transparent and timely communication with our shareholders, analysts, and media stakeholders.

Corporate Profile

Cambium Bio Limited - Corporate Presentation

Cambium Bio Limited - Corporate Presentation

Apr 6, 2024

Apr 6, 2024

ASX Announcements

Quarterly Cashflow Report and Business Update - period ending 31 March 2024

Quarterly Cashflow Report and Business Update - period ending 31 March 2024

Apr 30, 2024

Apr 30, 2024

Notice of change of interests of substantial holder

Notice of change of interests of substantial holder

Apr 11, 2024

Apr 11, 2024

Director's Appointment - Dr. Tseng

Director's Appointment - Dr. Tseng

Apr 11, 2024

Apr 11, 2024

Initial DIrector's Interest Notice - Dr. Tseng

Initial DIrector's Interest Notice - Dr. Tseng

Apr 11, 2024

Apr 11, 2024

Placement Shares Cleansing Notice

Placement Shares Cleansing Notice

Apr 10, 2024

Apr 10, 2024

For all Cambium Bio Limited ASX market announcements, click here

Financial Information

Cambium Bio Limited Half Year Report

Cambium Bio Limited Half Year Report

Dec 31, 2023

Dec 31, 2023

Cambium Bio Limited Annual Report

Cambium Bio Limited Annual Report

Jun 30, 2023

Jun 30, 2023

News Releases

Regeneus trebles on back of merger deal (Sydney Morning Herald)

Regeneus trebles on back of merger deal (Sydney Morning Herald)

Apr 5, 2024

Apr 5, 2024

Cambium Bio to enter ASX through backdoor listing via merger with Regeneus to treat dry eye disease

Cambium Bio to enter ASX through backdoor listing via merger with Regeneus to treat dry eye disease

Feb 6, 2024

Feb 6, 2024

Events and Presentations

Meet Cambium Bio team at BIO International Convention in San Diego

Meet Cambium Bio team at BIO International Convention in San Diego

Apr 17, 2024

Apr 17, 2024